Overview of ICH Guidelines (Q, S, E, M series) MCQs With Answer
Introduction: This quiz collection is designed for M.Pharm students to reinforce and test their understanding of core ICH guidelines relevant to pharmaceutical quality, safety, clinical development, and regulatory submission format. The questions emphasize practical concepts from the Q-series (quality, impurities, stability, and lifecycle), S-series (nonclinical safety and toxicology), E-series (clinical practice, safety reporting and trial design), and M-series (Common Technical Document structure). Each MCQ targets areas you will encounter in QA/QC, regulatory affairs, and dossier preparation. Use these items to prepare for exams, viva voce or to self-assess your readiness for regulatory roles in the pharmaceutical industry.
Q1. Which area is primarily covered by the ICH Q1 guideline series?
- Clinical trial conduct and patient safety
- Stability testing and storage conditions for drug substances and products
- Nonclinical toxicology study design
- Electronic submission standards for regulatory authorities
Correct Answer: Stability testing and storage conditions for drug substances and products
Q2. ICH Q2(R1) mainly provides guidance on which topic?
- Requirements for carcinogenicity testing
- Validation of analytical procedures and assay validation parameters
- Clinical study report structure
- Quality risk management tools and methods
Correct Answer: Validation of analytical procedures and assay validation parameters
Q3. The ICH Q3D guideline specifically addresses which type of impurities?
- Organic impurities and degradation products
- Microbial contamination limits
- Elemental (heavy metal) impurities and their control
- Residual solvents from synthesis
Correct Answer: Elemental (heavy metal) impurities and their control
Q4. What is the primary focus of ICH Q5 guidelines?
- Good Clinical Practice (GCP) implementation
- Quality guidance for biotechnological/biological products including cell substrates and characterization
- Pharmaceutical development and formulation optimization
- Nonclinical safety pharmacology study design
Correct Answer: Quality guidance for biotechnological/biological products including cell substrates and characterization
Q5. Which ICH Q guideline is centered on pharmaceutical development and understanding critical quality attributes (CQAs)?
- Q1 Stability
- Q2 Analytical Validation
- Q8 Pharmaceutical Development
- Q11 Impurities in new drug substances
Correct Answer: Q8 Pharmaceutical Development
Q6. ICH Q9 provides guidance primarily on which concept important for QC/QA?
- Clinical data reporting standards
- Quality Risk Management (QRM) principles and tools
- Standardized CTD formatting for dossiers
- Harmonized pharmacopoeial monographs
Correct Answer: Quality Risk Management (QRM) principles and tools
Q7. The ICH S1 guideline series deals mainly with what type of nonclinical evaluation?
- Assessment of genotoxic impurities
- Carcinogenicity testing strategies for pharmaceuticals
- Reproductive and developmental toxicity testing
- Good Laboratory Practice (GLP) implementation
Correct Answer: Carcinogenicity testing strategies for pharmaceuticals
Q8. ICH S2(R1) guidance pertains to which nonclinical testing area?
- Safety pharmacology core battery tests
- Genotoxicity testing and interpretation of results
- Biocompatibility of excipients
- Elemental impurities assessment
Correct Answer: Genotoxicity testing and interpretation of results
Q9. Which topic is the focus of ICH S5 guidelines?
- Environmental risk assessment of pharmaceuticals
- Toxicity to reproduction and developmental toxicity testing
- Clinical pharmacology study design
- Analytical method validation
Correct Answer: Toxicity to reproduction and developmental toxicity testing
Q10. ICH S6 provides guidance specifically for which category of products?
- Small-molecule oral solid dosage forms
- Biotechnology-derived pharmaceuticals and recombinant products
- Topical dermatological preparations
- Radiopharmaceuticals
Correct Answer: Biotechnology-derived pharmaceuticals and recombinant products
Q11. The ICH S7 guideline series is intended to guide which type of nonclinical studies?
- Toxicokinetic bioanalysis validation
- Safety pharmacology studies assessing vital organ systems (core battery)
- Clinical endpoint selection for oncology trials
- Stability testing under ICH storage conditions
Correct Answer: Safety pharmacology studies assessing vital organ systems (core battery)
Q12. Which ICH E guideline describes Good Clinical Practice (GCP) standards?
- E3 Clinical Study Report
- E6 Good Clinical Practice
- E9 Statistical Principles for Clinical Trials
- E2 Pharmacovigilance and safety reporting
Correct Answer: E6 Good Clinical Practice
Q13. The ICH E3 guideline provides guidance on which component of regulatory submissions?
- Nonclinical toxicology study protocols
- Format and content of the Clinical Study Report (CSR)
- Analytical method validation procedure
- Manufacturing site inspection procedures
Correct Answer: Format and content of the Clinical Study Report (CSR)
Q14. ICH E2A is concerned primarily with which aspect of drug safety?
- Standardization of statistical analysis plans
- Clinical safety data management and expedited reporting of adverse events
- Design of pediatric clinical trials
- Structure of quality (Module 3) in the CTD
Correct Answer: Clinical safety data management and expedited reporting of adverse events
Q15. What does ICH E5 address that is important for global clinical development?
- Quality risk management techniques
- Ethnic factors and acceptability of foreign clinical data (bridging data)
- Nonclinical reproductive toxicity testing
- Elemental impurities in drug products
Correct Answer: Ethnic factors and acceptability of foreign clinical data (bridging data)
Q16. ICH E9 is best known for guidance on what aspect of clinical trials?
- Good Manufacturing Practice for investigational products
- Statistical principles for design and analysis of clinical trials
- Nonclinical safety assessment timelines
- Submission format for chemical quality data
Correct Answer: Statistical principles for design and analysis of clinical trials
Q17. The ICH E11 guideline provides recommendations for which special population in clinical studies?
- Elderly subjects (geriatrics)
- Pediatric populations and pediatric study considerations
- Patients with hepatic impairment
Correct Answer: Pediatric populations and pediatric study considerations
Q18. What is the main purpose of the ICH M4 Common Technical Document (CTD)?
- To specify nonclinical safety testing protocols
- To harmonize the format and content of regulatory submissions across regions
- To define methods for impurity profiling
- To establish GCP training standards
Correct Answer: To harmonize the format and content of regulatory submissions across regions
Q19. Within the CTD (M4), which module contains the detailed pharmaceutical quality (CMC) information?
- Module 1 — Regional administrative information
- Module 2 — Summaries and overviews
- Module 3 — Quality (chemistry, manufacturing and controls)
- Module 5 — Clinical study reports
Correct Answer: Module 3 — Quality (chemistry, manufacturing and controls)
Q20. Which statement best reflects a key benefit of using the ICH M4 CTD format for a regulatory dossier?
- It eliminates the need for region-specific information entirely
- It standardizes dossier structure so reviewers can find information consistently across submissions
- It prescribes exact analytical methods to be used in testing
- It replaces all regulatory requirements for clinical data quality
Correct Answer: It standardizes dossier structure so reviewers can find information consistently across submissions
I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com